Table 4 Summary of studies evaluating the efficacy of salvage chemotherapy in patients with advanced esophageal squamous cell carcinoma.
From: The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
Author | n | Study type | Treatment regimen | ORR (%) | DCR (%) | MST (m) | Ref |
|---|---|---|---|---|---|---|---|
Nomura, et al. | 16 | Retro | Fluorouracil or S-1 | 13.3 | 66.7 | 12.9 | |
147 | BSC | NA | NA | 4.3 | |||
Akutsu, et al. | 20 | Retro | S-1 | 25 | 60 | 10.8 | |
Tamaoki, et al. | 15 | Retro | S-1 | 6.6 | 66.7 | 10 | |
Ito et, al. | 11 | Retro | S-1 | 22.2 | 36.4 | 11.7 | |
Nomura, et al. | 16 | Phase 2 | S-1 | 13.3 | 46.7 | 8.4 | |
Present study | 39 | Retro | FOLFOX | 4 | 36 | 7.4 |
